Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic dysfunction in Parkinson's disease
Vincenza Bagetta, Veronica Ghiglieri, Carmelo Sgobio, et al.
Biochemical Society Transactions (2010) Vol. 38, Iss. 2, pp. 493-497
Closed Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Bai Lu, Guhan Nagappan, Xiao-Ming Guan, et al.
Nature reviews. Neuroscience (2013) Vol. 14, Iss. 6, pp. 401-416
Closed Access | Times Cited: 672
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
K. A. Jellinger
Movement Disorders (2011) Vol. 27, Iss. 1, pp. 8-30
Closed Access | Times Cited: 430
The BCM theory of synapse modification at 30: interaction of theory with experiment
Leon N. Cooper, Mark F. Bear
Nature reviews. Neuroscience (2012) Vol. 13, Iss. 11, pp. 798-810
Closed Access | Times Cited: 372
Exercise Benefits Brain Function: The Monoamine Connection
Tzu-Wei Lin, Yu‐Min Kuo
Brain Sciences (2013) Vol. 3, Iss. 1, pp. 39-53
Open Access | Times Cited: 313
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jéssika Cristina Bridi, Frank Hirth
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 302
When pain gets stuck: the evolution of pain chronification and treatment resistance
David Borsook, Andrew M. Youssef, Laura E. Simons, et al.
Pain (2018) Vol. 159, Iss. 12, pp. 2421-2436
Open Access | Times Cited: 235
Role of Metabotropic Glutamate Receptors in Neurological Disorders
Rosalia Crupi, Daniela Impellizzeri, Salvatore Cuzzocrea
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 211
Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo
Phillip M. Rappold, Mei Cui, Jonathan C. Grima, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 198
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
David Matuskey, Sule Tinaz, Kyle C. Wilcox, et al.
Annals of Neurology (2020) Vol. 87, Iss. 3, pp. 329-338
Open Access | Times Cited: 149
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Giulia Ambrosi, Silvia Cerri, Fabio Blandini
Journal of Neural Transmission (2013) Vol. 121, Iss. 8, pp. 849-859
Closed Access | Times Cited: 182
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo
Abid Oueslati, Bernard L. Schneider, Patrick Aebischer, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 41
Open Access | Times Cited: 173
Long-Term Potentiation at CA3–CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress
Ashok Kumar
Frontiers in Aging Neuroscience (2011) Vol. 3
Open Access | Times Cited: 148
Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease
Dominik Haddad, Ken Nakamura
FEBS Letters (2015) Vol. 589, Iss. 24PartA, pp. 3702-3713
Open Access | Times Cited: 135
The Role of Microglia in Synaptic Stripping and Synaptic Degeneration: A Revised Perspective
V. Hugh Perry, Vincent O’Connor
ASN NEURO (2010) Vol. 2, Iss. 5, pp. AN20100024-AN20100024
Open Access | Times Cited: 130
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
Francisco J. Carvajal, Hayley A. Mattison, Waldo Cerpa
Neural Plasticity (2016) Vol. 2016, pp. 1-20
Open Access | Times Cited: 129
Cognitive decline in Parkinson’s disease: the complex picture
Roberta Biundo, Luca Weis, Angelo Antonini
npj Parkinson s Disease (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 128
Beneficial Effects of Flavonoids Against Parkinson's Disease
Un Ju Jung, Sang Ryong Kim
Journal of Medicinal Food (2018) Vol. 21, Iss. 5, pp. 421-432
Closed Access | Times Cited: 125
Communication breakdown: The impact of ageing on synapse structure
Ronald S. Petralia, Mark P. Mattson, Pamela J. Yao
Ageing Research Reviews (2014) Vol. 14, pp. 31-42
Open Access | Times Cited: 113
Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates
Songye Li, Zhengxin Cai, Xiaoai Wu, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 3, pp. 1544-1554
Open Access | Times Cited: 97
Activity Shapes Neural Circuit Form and Function: A Historical Perspective
Yuan Pan, Michelle Monje
Journal of Neuroscience (2020) Vol. 40, Iss. 5, pp. 944-954
Open Access | Times Cited: 77
Pathological Functions of LRRK2 in Parkinson’s Disease
Ga Ram Jeong, Byoung Dae Lee
Cells (2020) Vol. 9, Iss. 12, pp. 2565-2565
Open Access | Times Cited: 72
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Idan Rosh, Utkarsh Tripathi, Yara Hussein, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease
Vincenza Bagetta, Barbara Picconi, S Marinucci, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 35, pp. 12513-12522
Open Access | Times Cited: 99
Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
Khaled-Ezaheir Bennouar, Michelle A. Uberti, Christophe Melon, et al.
Neuropharmacology (2012) Vol. 66, pp. 158-169
Closed Access | Times Cited: 94
Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
Saktimayee M. Roy, Valerie Grum‐Tokars, James P. Schavocky, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 666-680
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top